Connect with us

Health

Researchers develop a novel probiotic formulation with high anti-SARS-CoV-2 potency – News-Medical.Net

A team of international scientists recently conducted a randomized clinical trial to assess the safety and efficacy profiles of a novel probiotic formulation in…

Published

on

Article feature image
ADVERTISEMENT

A team of international scientists recently conducted a randomized clinical trial to assess the safety and efficacy profiles of a novel probiotic formulation in symptomatic coronavirus disease 2019 (COVID-19) patients.
The findings indicate that the probiotic formulation is highly effective in reducing symptom severity in COVID-19 patients without causing any adverse events. The study is currently available on the medRxiv* preprint server.
Background
Severe acute respiratory syndrome coronavirus…

Click here to view the original article.

Continue Reading
Advertisement
Advertisement

Trending